Triple-Model Immunoassays with the Self-Assemblies of Three-in-One Small Molecules as Signaling Labels.

Zhaojiang Yu, Wenqi Yuan, Mingyi Qiao, Lin Liu

Abstract read

In one paragraph

Article in Biosensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhaojiang YuCollege of Chemistry and Chemical Engineering, Anyang Normal University, Anyang 455000, China.

Wenqi YuanCollege of Chemistry and Chemical Engineering, Anyang Normal University, Anyang 455000, China.

Mingyi QiaoCollege of Chemistry and Chemical Engineering, Anyang Normal University, Anyang 455000, China.

Lin LiuCollege of Chemistry and Chemical Engineering, Anyang Normal University, Anyang 455000, China.ORCID 0000-0001-7982-6005

Funding

Program for Innovative Research Team of Science and Technology in Anyang Normal University 2023ASCXTD02

6 · The paper itself

Abstract

Multiple-mode immunoassays have the advantages of self-correction, self-validation, and high accuracy and reliability. In this work, we developed a strategy for the design of triple-mode immunoassays with the self-assemblies of three-in-one small molecules as signal reporters. Pyrroloquinoline quinone (PQQ), with a well-defined redox peak and excellent spectroscopic and fluorescent signals, was chosen as the signaling molecule. PQQ was coordinated with Cu

Indexed as

Biosensing TechniquesCarcinoembryonic AntigenCopperHumansImmunoassayLimit of DetectionMetal NanoparticlesCarcinoembryonic AntigenCopperbiorecognitionmultiple-mode immunoassayspyrroloquinoline quinoneself-assemblysignal amplification

Identifiers

PMID41294722

DOI10.3390/bios15110710

PMCPMC12650134

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.